Morgan Stanley Reaffirms Overweight Rating on Z.AI With HK$1,800 Target

Deep News
3小时前

Morgan Stanley has issued a research report indicating that Z.AI (02513) achieved an annualized recurring revenue (ARR) of $1.8 billion by mid-September, while also raising its year-end ARR guidance from $2.4 billion to $3 billion. The firm reaffirmed its "Overweight" rating on the stock with a target price of HK$1,800.

The bank noted that the management framework shows approximately $5 billion in funding could support around 94,000 GPUs, with roughly 40% allocated for training and 60% for inference purposes. The approximately 56,000 inference GPUs imply a theoretical annual revenue ceiling of about RMB 41 billion, which does not yet account for utilization rates and actual pricing realization, with theoretical inference gross margins potentially reaching as high as 80%.

Easing compute bottlenecks is expected to unlock the next phase of growth, while cloud partnerships could improve capital efficiency and global distribution, with revenue sharing contributions anticipated to begin in October. On the research and development front, the training allocation could support average annual training expenditures of approximately RMB 3 billion over four years, sufficient to underpin multiple rounds of GLM-5.3-class or larger model training.

Furthermore, the bank pointed out that Cowork is expanding beyond coding, with cybersecurity emerging as the first scaled vertical application. More than 100 cybersecurity companies have already integrated GLM models, and orders for GLM-5.3 have surpassed RMB 1 billion within one month of its launch.

The upward revision in ARR is primarily driven by three key engines: coding, cloud partnerships, and Cowork. The critical discussion has shifted from whether demand exists to how quickly incremental compute capacity, partner distribution channels, and vertical workflow monetization can translate into recognized revenue and sustainable gross margins.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10